Rating: +1

Bill Summary:
H0136 creates a new Section 41-351 in Idaho Code to establish annual reporting requirements for entities participating in the federal 340B drug pricing program. These “340B covered entities,” including contracted pharmacies, must report by April 1 of each year detailed financial data about their use of the program—such as drug acquisition costs, payments received, payments made to pharmacies, number of claims, and how savings are used (e.g., charity care or community health benefits). The data must be categorized by payer type (Commercial, Medicaid, Medicare). While the raw data is confidential, the State Controller’s Office must publish an aggregated, public report by November 15 each year on the Transparent Idaho website. The Attorney General is also authorized to use the reported data to investigate Medicaid fraud or compliance issues.

Reason for Rating:
H0136 supports the Idaho Republican Party Platform by advancing transparency, fiscal accountability, and oversight of government-linked healthcare programs. While it does not restrict or regulate participation in the 340B program itself, it brings needed sunlight to a federally subsidized drug pricing system that often operates with little state-level scrutiny. The bill empowers Idaho to ensure that taxpayer-subsidized savings are truly benefiting indigent care and not padding administrative budgets. It balances data privacy with public accountability, avoids creating new bureaucracy, and enables lawful enforcement. This reflects core conservative values of government transparency, anti-fraud enforcement, and responsible stewardship of public resources.